一种检测禽偏肺病毒疫苗效力的新方法:攻毒后气管纤毛活动性评估
研究旨在建立简易可重复的鸡禽偏肺病毒(aMPV)感染模型以检测疫苗效力,假设气管外植体纤毛活动性评估适用于攻毒后aMPV疫苗效力评价。商业来源鸡(含母源抗体)或SPF鸡在1日龄接种疫苗,于17日龄至16周龄不同日龄攻毒,评估纤毛活动性及临床症状、增重和血清抗体。所有实验中疫苗在纤毛活动性方面均提供攻毒保护,但增重和临床症状并非在所有实验中均适合显示效力,且仅SPF动物接种后观察到很弱的血清学反应。
要点
- 气管外植体纤毛活动性可作为17日龄至16周龄商业或SPF鸡aMPV疫苗效力检测的合适方法。
- 所有实验中疫苗在纤毛活动性方面均提供攻毒保护。
- 增重和临床症状并非在所有实验中均适合显示效力,仅SPF动物接种后见很弱血清学反应。
核心结论
- 研究结果证实了工作假设:气管外植体纤毛活动性是检测17日龄至16周龄商业或SPF鸡aMPV疫苗的合适方法。
研究设计与样本
- 商业来源鸡(含母源抗体)或SPF鸡于1日龄接种疫苗,于17日龄至16周龄不同日龄攻毒。
- 评估指标包括气管外植体纤毛活动性、临床症状、增重和血清抗体。
主要发现
- 所有实验中疫苗在纤毛活动性方面均提供攻毒保护。
- 增重和临床症状并非在所有实验中均适合显示效力。
- 仅SPF动物接种后观察到很弱的血清学反应。
关键数值与推荐
- 气管外植体纤毛活动性评估用于aMPV疫苗效力检测,适用鸡龄为17日龄至16周龄。
临床怎么用
- 作者认为气管外植体纤毛活动性可用于商业或SPF鸡17日龄至16周龄的aMPV疫苗效力检测。
局限性
- 增重和临床症状并非在所有实验中均适合显示效力。
- 仅SPF动物接种后观察到很弱的血清学反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Avian metapneumovirus (aMPV) infects turkeys and chickens. It replicates primarily in the upper respiratory tract, causing respiratory disease. Animals may also exhibit lower feed and water consumption and weight loss. Despite the high morbidity and often high mortality associated with aMPV in the field, the pathogenicity of field isolates has been difficult to assess in the laboratory. Usually, only mild respiratory clinical signs with low presentation can be reproduced in experimental infections. Hence, the aim of this study was to develop a simple and reproducible aMPV infection model in chicken, to test vaccines' efficacy. It was hypothesized that the evaluation of ciliary activity of tracheal explants, a parameter used in the evaluation of avian infectious bronchitis vaccines, would be suitable for evaluating aMPV vaccines' efficacy after an experimental challenge. Chickens of commercial origin, with maternally-derived antibodies or SPF chickens were vaccinated at one day of age. Challenges were performed at different ages (17 days to 16 weeks of age). Ciliary activity of tracheal explants was evaluated together with more common parameters of efficacy: clinical signs, body weight gain and serum antibodies. In all cases, the vaccine provided protection against the challenge in terms of ciliary activity. Body weight gain and clinical signs were not suitable in all the experiments for showing efficacy, and a very mild serologic response was observed after vaccination, and only in SPF animals. The results of this study confirmed the working hypothesis: that the ciliary activity of tracheal explants is a suitable method for testing aMPV vaccines in commercial or SPF chickens in ages from 17 days to 16 weeks.
引用
- Marzo E, Guirado E, Taberner E, et al. A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge. Vaccine. 2025. PMID: 40876141. doi:10.1016/j.vaccine.2025.127641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。